Bioactive hydrogel microcapsules for guiding stem cell fate decisions by release and reloading of growth factors.
Ontology highlight
ABSTRACT: Human pluripotent stem cells (hPSC) hold considerable promise as a source of adult cells for treatment of diseases ranging from diabetes to liver failure. Some of the challenges that limit the clinical/translational impact of hPSCs are high cost and difficulty in scaling-up of existing differentiation protocols. In this paper, we sought to address these challenges through the development of bioactive microcapsules. A co-axial flow focusing microfluidic device was used to encapsulate hPSCs in microcapsules comprised of an aqueous core and a hydrogel shell. Importantly, the shell contained heparin moieties for growth factor (GF) binding and release. The aqueous core enabled rapid aggregation of hPSCs into 3D spheroids while the bioactive hydrogel shell was used to load inductive cues driving
SUBMITTER: Gwon K
PROVIDER: S-EPMC8941170 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA